These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8117533)

  • 1. Malignant hyperthermia and associated disorders.
    Allen GC
    Curr Opin Rheumatol; 1993 Nov; 5(6):719-24. PubMed ID: 8117533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Malignant hyperthermia--a hereditary and potentially life-threatening condition].
    Haugen T; Toft M; Müller CR; Aasly J
    Tidsskr Nor Laegeforen; 2005 Oct; 125(20):2792-4. PubMed ID: 16244682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant hyperthermia: an inherited disorder of skeletal muscle Ca+ regulation.
    Louis CF; Balog EM; Fruen BR
    Biosci Rep; 2001 Apr; 21(2):155-68. PubMed ID: 11725864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Characterization of C-terminal Ryanodine Receptor 1 Variants Associated with Central Core Disease or Malignant Hyperthermia.
    Parker R; Schiemann AH; Langton E; Bulger T; Pollock N; Bjorksten A; Gillies R; Hutchinson D; Roxburgh R; Stowell KM
    J Neuromuscul Dis; 2017; 4(2):147-158. PubMed ID: 28527222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Core myopathies and malignant hyperthermia susceptibility: a review.
    Brislin RP; Theroux MC
    Paediatr Anaesth; 2013 Sep; 23(9):834-41. PubMed ID: 23617272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical features of malignant hyperthermia crisis].
    Cornet C; Moeller R; Laxenaire MC
    Ann Fr Anesth Reanim; 1989; 8(5):435-43. PubMed ID: 2516711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor.
    Monnier N; Romero NB; Lerale J; Nivoche Y; Qi D; MacLennan DH; Fardeau M; Lunardi J
    Hum Mol Genet; 2000 Nov; 9(18):2599-608. PubMed ID: 11063719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for mutations in the RYR1 gene in families with malignant hyperthermia.
    Muniz VP; Silva HC; Tsanaclis AM; Vainzof M
    J Mol Neurosci; 2003; 21(1):35-42. PubMed ID: 14500992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propofol-induced changes in myoplasmic calcium concentrations in cultured human skeletal muscles from RYR1 mutation carriers.
    Migita T; Mukaida K; Kawamoto M; Kobayashi M; Nishino I; Yuget O
    Anaesth Intensive Care; 2007 Dec; 35(6):894-8. PubMed ID: 18084979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duchenne muscular dystrophy and malignant hyperthermia: a genetic study of the ryanodine receptor in 47 patients.
    Rohde D; Schmitt HJ; Winterpacht A; Münster T
    Eur J Anaesthesiol; 2014 Jun; 31(6):341-2. PubMed ID: 24557023
    [No Abstract]   [Full Text] [Related]  

  • 11. Heat production during anesthetic-induced malignant hyperthermia.
    Nelson TE
    Biosci Rep; 2001 Apr; 21(2):169-79. PubMed ID: 11725865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic mapping of the beta 1- and gamma-subunits of the human skeletal muscle L-type voltage-dependent calcium channel on chromosome 17q and exclusion as candidate genes for malignant hyperthermia susceptibility.
    Iles DE; Segers B; Sengers RC; Monsieurs K; Heytens L; Halsall PJ; Hopkins PM; Ellis FR; Hall-Curran JL; Stewart AD
    Hum Mol Genet; 1993 Jul; 2(7):863-8. PubMed ID: 8395940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in RYR1 in malignant hyperthermia and central core disease.
    Robinson R; Carpenter D; Shaw MA; Halsall J; Hopkins P
    Hum Mutat; 2006 Oct; 27(10):977-89. PubMed ID: 16917943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of a family with the skeletal muscle RYR1 mutation (c.7354C>T) associated with central core myopathy and malignant hyperthermia susceptibility.
    Taylor A; Lachlan K; Manners RM; Lotery AJ
    J Clin Neurosci; 2012 Jan; 19(1):65-70. PubMed ID: 22030266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant hyperthermia: still an issue for neuromuscular diseases?
    De Wel B; Claeys KG
    Curr Opin Neurol; 2018 Oct; 31(5):628-634. PubMed ID: 30015672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Malignant hyperthermia as a complication of anesthesia: predisposition is hereditary].
    Snoeck MM; Gielen MJ; Sengers RC; Padberg GW; Iles DE; Booij LH
    Ned Tijdschr Geneeskd; 1997 Mar; 141(13):616-9. PubMed ID: 9190536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromuscular conditions associated with malignant hyperthermia in paediatric patients: A 25-year retrospective study.
    Bamaga AK; Riazi S; Amburgey K; Ong S; Halliday W; Diamandis P; Guerguerian AM; Dowling JJ; Yoon G
    Neuromuscul Disord; 2016 Mar; 26(3):201-6. PubMed ID: 26951757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porcine malignant hyperthermia susceptibility: hypersensitive calcium-release mechanism of skeletal muscle sarcoplasmic reticulum.
    O'Brien PJ
    Can J Vet Res; 1986 Jul; 50(3):318-28. PubMed ID: 3742367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of ion-regulatory membrane proteins of excitation-contraction coupling and relaxation in inherited muscle diseases.
    Froemming GR; Ohlendieck K
    Front Biosci; 2001 Jan; 6():D65-74. PubMed ID: 11145921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat- and anesthesia-induced malignant hyperthermia in an RyR1 knock-in mouse.
    Chelu MG; Goonasekera SA; Durham WJ; Tang W; Lueck JD; Riehl J; Pessah IN; Zhang P; Bhattacharjee MB; Dirksen RT; Hamilton SL
    FASEB J; 2006 Feb; 20(2):329-30. PubMed ID: 16284304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.